Skip to content

A study of immunity

A study of immunity - A study of immunity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045317
Enrollment
64
Registered
2021-08-31
Start date
2021-09-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of polysaccharide-containing food daily for 12 weeks Intake of placebo food daily for 12 weeks

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males and females from 20 to 65 years of age

Exclusion criteria

Exclusion criteria: (1) Subjects who were unaware of cold or cold-like symptoms (2) Subjects who are taking drugs or quasi-drugs, supplements (3) Subjects who have a history of the allergic disease (4) Subjects who have under treatment or a history of serious disease (5) Subjects who have oral or dental problems (6) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (7) Subjects who are engaged in day / night shift work or midnight work, etc. (8) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (9) Subjects who intend to become pregnant or lactating (10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (11) Subjects who are judged as unsuitable for the study by the investigator

Design outcomes

Primary

MeasureTime frame
mDC after 12 weeks

Secondary

MeasureTime frame
Immune index ( s-IgA, interleukin, interferon, natural killer cell ) and symptoms score after 12 weeks

Countries

Japan

Contacts

Public ContactKaori Yoshimura

EP Mediate Co., Ltd. Development Business Headquarters, TTC Center, Trial Planning Department

yoshimura.kaori265@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026